[Optimal 3] A Phase Iii Trial To Evaluate The Efficacy And Safety Of Dhp107 (Liporaxel, Oral Paclitaxel) Compared To Taxol (Iv Paclitaxel) As First Line Therapy In Patients With Recurrent Or Metastatic Her2 Negative Breast Cancer (Bc) (Nct03315364).
JOURNAL OF CLINICAL ONCOLOGY(2020)
摘要
TPS1106Background: Paclitaxel is a microtubule-stabilizing drug used for various cancers including breast cancer (BC) and gastric cancer (GC). DHP107 is an oral paclitaxel solution formulated with ...
更多查看译文
关键词
oral paclitaxel,iv paclitaxel,negative breast cancer,breast cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要